ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Geriatric Medicine

Top Geriatric Medicine Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ORLANDO CARPIO M.D.

Geriatric Medicine

28,289

$1.44M

627
553 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

2%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $56

FARHAD GHANAAT

Geriatric Medicine

25,416

$1.22M

819
809 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 27%

$48
Average prescription price

Avg: $56

MALAY DAS M.D

Geriatric Medicine

20,887

$1.09M

746
743 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

3%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $56

ZHENG-BO HUANG M.D.

Geriatric Medicine

20,866

$1.34M

570
542 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $56

JAMES SIMCOE MD

Geriatric Medicine

19,582

$934K

373
356 are 65+

17%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$48
Average prescription price

Avg: $56

JONATHAN CHANG M.D.

Geriatric Medicine

18,830

$1.03M

727
614 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

3%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $56

AMIT SAXENA MD

Geriatric Medicine

18,294

$908K

528
435 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

2%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $56

ALEXANDER KARLIC MD

Geriatric Medicine

17,234

$1.01M

699
649 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $56

MADHUKAR BHOOMIREDDI MD

Geriatric Medicine

16,934

$941K

321
299 are 65+

17%
patients receiving schedule two controlled substances

Avg: 9%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $56

RENANTE IGNACIO MD

Geriatric Medicine

15,989

$781K

492
450 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $56

RACHEL AVGUSH MD

Geriatric Medicine

15,759

$1.08M

458
388 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

3%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $56

MICHAEL BURKE MD

Geriatric Medicine

15,292

$778K

400
381 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

12%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $56

MALGORZATA LANGE MD

Geriatric Medicine

14,878

$718K

460
460 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

5%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$48
Average prescription price

Avg: $56

DANIEL ZATREANU MD

Geriatric Medicine

14,646

$936K

579
553 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $56

NAFEA ALI M.D.

Geriatric Medicine

14,442

$616K

481
473 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$43
Average prescription price

Avg: $56

STEFANO FRANCO MD

Geriatric Medicine

13,990

$739K

541
439 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $56

GREGORIO REYES M.D.

Geriatric Medicine

13,887

$721K

484
431 are 65+

17%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $56

BRUCE BERMAN M.D.

Geriatric Medicine

13,871

$1.46M

782
642 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

3%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 27%

$105
Average prescription price

Avg: $56

DEVANG DAVE MD

Geriatric Medicine

13,842

$740K

385
358 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $56

GERMAINE SAINT-AUDE MD

Geriatric Medicine

13,828

$14.7K

222
201 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$1
Average prescription price

Avg: $56

ROBERT RINGLER MD

Geriatric Medicine

13,665

$835K

292
287 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

12%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $56

JEANNE BISHOP MD

Geriatric Medicine

13,452

$914K

375
353 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

3%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $56

MARIE REID DURANT MD

Geriatric Medicine

13,443

$677K

460
455 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

4%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $56

JAIKUMAR RAVUNNIARATH MD

Geriatric Medicine

13,011

$728K

210
199 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $56

FAINA KOGAN MD

Geriatric Medicine

12,964

$1.48M

276
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 27%

$114
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank